4.7 Article

Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines

Journal

JOURNAL OF NEUROSCIENCE
Volume 34, Issue 46, Pages 15150-15158

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.3223-14.2014

Keywords

-

Categories

Funding

  1. National Institute on Drug Abuse, National Institutes of Health

Ask authors/readers for more resources

The abuse of synthetic psychoactive substances known as designer drugs, or new psychoactive substances (NPS), is increasing at an alarming rate. NPS are purchased as alternatives to traditional illicit drugs of abuse and are manufactured to circumvent laws regulating the sale and use of controlled substances. Synthetic cathinones (i.e., bath salts) and synthetic cannabinoids (i.e., spice) are two types of NPS that have received substantial media attention. Although low recreational doses of bath salts or spice compounds can produce desirable effects, high doses or chronic exposure often leads to dangerous medical consequences, including psychosis, violent behaviors, tachycardia, hyperthermia, and even death. Despite the popularity of NPS, there is a paucity of scientific data about these drugs. Here we provide a brief up-to-date review describing the mechanisms of action and neurobiological effects of synthetic cathinones and cannabinoids.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemical Research Methods

Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants

Simon D. Brandt, Laura Carlino, Pierce Kavanagh, Folker Westphal, Wolfgang Dreiseitel, Geraldine Dowling, Michael H. Baumann, Harald H. Sitte, Adam L. Halberstadt

DRUG TESTING AND ANALYSIS (2020)

Review Neurosciences

Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction

Ernesto Solis, Kevin N. Hascup, Erin R. Hascup

JOURNAL OF ALZHEIMERS DISEASE (2020)

Article Clinical Neurology

Sex, species and age: Effects of rodent demographics on the pharmacology of Δ9-tetrahydrocanabinol

Jenny L. Wiley, Daniel G. Barrus, Charlotte E. Farquhar, Timothy W. Lefever, Thomas F. Gamage

Summary: The study investigated the effects of age, sex, and rodent species on the psychoactive impact of intraperitoneal THC and its metabolite 11-OH-THC. The results show that 11-OH-THC exhibited higher potency in some aspects compared to THC, suggesting that species is a crucial design consideration in preclinical studies of phytocannabinoids.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)

Article Neurosciences

The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats

Simon D. Brandt, Hailey M. Walters, John S. Partilla, Bruce E. Blough, Pierce V. Kavanagh, Michael H. Baumann

PSYCHOPHARMACOLOGY (2020)

Article Substance Abuse

Δ9-Tetrahydrocannabinol discrimination: Effects of route of administration in rats

L. Jenny Wiley, I. Shanequa Taylor, A. Julie Marusich

Summary: The study examined the effects of THC administered through different routes on rats. Results showed varying effects of THC across different routes of administration, providing empirical evidence for choosing the route of administration for mechanistic investigation of THC's pharmacology. Animal models using translationally relevant routes of administration may lead to more accurate predictions of THC effects in humans.

DRUG AND ALCOHOL DEPENDENCE (2021)

Article Chemistry, Analytical

Thermal Degradants Identified from the Vaping of Vitamin E Acetate

Alexander L. Kovach, Randi R. Carter, Jonathan W. Thornburg, Robert Wiethe, Timothy R. Fennell, Jenny L. Wiley

Summary: Studies have found that vitamin E acetate undergoes thermal degradation in electronic vaping devices and is considered a major contributor to e-cigarette or vaping product use-associated lung injuries. By analyzing the degradation products of vitamin E acetate, researchers have identified two major compounds and suggested their potential as biomarkers for exposure and toxicity assessment.

JOURNAL OF ANALYTICAL TOXICOLOGY (2022)

Article Pharmacology & Pharmacy

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018

David B. Finlay, Thuy Nguyen, Thomas F. Gamage, Shuli Chen, Daniel G. Barrus, Purvi R. Patel, Brian F. Thomas, Jenny L. Wiley, Yanan Zhang, Michelle Glass

Summary: This study compared the synthetic cannabinoid receptor agonist EG-018 and its analogues with existing putative neutral antagonists of CB1 receptor. The results showed highly variable signaling outcomes for EG-018 analogues, with some compounds demonstrating potential as neutral antagonists. These findings provide important insights for the development of CB1 neutral antagonists.

PHARMACOLOGY RESEARCH & PERSPECTIVES (2022)

Article Chemistry, Multidisciplinary

Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines

Grant C. Glatfelter, Duyen N. K. Pham, Donna Walther, James A. Golen, Andrew R. Chadeayne, Michael H. Baumann, David R. Manke

Summary: This study reported the synthesis, structural characterization, and pharmacological activity of several quaternary tryptammonium analogues. The results showed that these analogues do not target 5-HT2A sites but may have affinity for the serotonin transporter (SERT), providing potential templates for exploring selective actions at SERT.

ACS OMEGA (2022)

Article Substance Abuse

Assessment of dependence potential and abuse liability of ?8-tetrahydrocannabinol in mice

S. O. Vanegas, A. M. Reck, C. E. Rodriguez, J. A. Marusich, O. Yassin, G. Sotzing, J. L. Wiley, S. G. Kinsey

Summary: This study evaluates the effects of acute and repeated exposure to delta(8)-THC and finds that it produces similar effects to delta(9)-THC, including risk of drug dependence and abuse liability.

DRUG AND ALCOHOL DEPENDENCE (2022)

Article Behavioral Sciences

In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists

Julie A. Marusich, Thomas F. Gamage, Yanan Zhang, Luli R. Akinfiresoye, Jenny L. Wiley

Summary: Synthetic cannabinoid receptor agonists (SCRAs) are a novel class of psychoactive substances that bind to and activate CB1 receptors in the brain.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2022)

Article Behavioral Sciences

The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism

David B. Finlay, Warwick Mackie, Hunter D. J. Webb, Lucy R. Thomsen, Mhairi Nimick, Rhonda J. Rosengren, Julie A. Marusich, Michelle Glass, Jenny L. Wiley

Summary: AMB-FUBINACA is a synthetic cannabinoid receptor agonist associated with abuse and health harm. The study aimed to investigate the interactions between AMB-FUBINACA and pFPP in rats and mice. The results suggest that pFPP may attenuate some physiological effects of AMB-FUBINACA in rats, but there is little evidence of direct receptor interactions. Overall, combining pFPP and AMB-FUBINACA is unlikely to result in increased harm/toxicity.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2023)

Article Chemistry, Medicinal

Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice

Grant C. Glatfelter, Marilyn Naeem, Duyen N. K. Pham, James A. Golen, Andrew R. Chadeayne, David R. Manke, Michael H. Baumann

Summary: Analogues of psilocybin are being sold and developed as potential medications for psychedelic-assisted therapies. These analogues produce psychedelic-like effects primarily by agonist activity at serotonin 2A receptors. The present study examines the targeted receptors and the effects of a specific psilocybin analogue, 4-propionoxy-N,N-dimethyltryptamine, in mice.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2023)

Article Cardiac & Cardiovascular Systems

Δ9-Tetrahydrocannabinol Effects on Respiration and Heart Rate Across Route of Administration in Female and Male Mice

Lucas T. Laudermilk, Julie A. Marusich, Jenny L. Wiley

Summary: This study investigates the effects of sex and route of administration on THC-induced changes in cardiopulmonary phenotypes in mice. The results demonstrate that THC alters respiratory minute volume and heart rate across different administration routes, with varying effects in duration and direction.

CARDIOVASCULAR TOXICOLOGY (2023)

Article Behavioral Sciences

Experimenter administered Δ9-THC decreases nicotine self-administration in a rat model

Antony D. Abraham, Jenny L. Wiley, Julie A. Marusich

Summary: This study found that THC has an impact on nicotine intake in rat models, decreasing self-administration of nicotine and altering the dose-effect curve. Unlike nicotine, THC does not affect the response to sucrose.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2023)

Article Substance Abuse

Δ9-tetrahydrocannabinol discrimination: Effects of route of administration in mice

Julie A. Marusich, Jenny L. Wiley

Summary: This study examined the effect of different routes of administration on the potency and time course of THC's discriminative stimulus properties. The results showed that THC administered through various routes produced similar stimulus effects. These findings have implications for predicting THC's effects in humans.

DRUG AND ALCOHOL DEPENDENCE REPORTS (2023)

No Data Available